Willow Creek Capital Management Inc. Purchases 2,796 Shares of Danaher Corporation $DHR

Willow Creek Capital Management Inc. raised its position in Danaher Corporation (NYSE:DHR) by 122.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,072 shares of the conglomerate’s stock after purchasing an additional 2,796 shares during the quarter. Danaher accounts for approximately 1.1% of Willow Creek Capital Management Inc.’s portfolio, making the stock its 28th largest holding. Willow Creek Capital Management Inc.’s holdings in Danaher were worth $1,124,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Gunderson Capital Management LLC acquired a new stake in Danaher in the third quarter valued at approximately $765,000. EP Wealth Advisors LLC purchased a new stake in shares of Danaher during the second quarter valued at approximately $3,807,000. Puzo Michael J purchased a new position in shares of Danaher in the second quarter valued at $8,624,000. Madison Asset Management LLC acquired a new stake in Danaher during the 2nd quarter valued at $85,451,000. Finally, First Nebraska Trust Co purchased a new stake in Danaher during the 2nd quarter worth $14,106,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Down 1.1%

Shares of DHR stock traded down $2.63 during trading hours on Friday, hitting $228.87. 3,516,366 shares of the company were exchanged, compared to its average volume of 4,667,069. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The business’s 50-day simple moving average is $214.04 and its two-hundred day simple moving average is $195.97. The stock has a market capitalization of $160.89 billion, a price-to-earnings ratio of 40.65, a P/E/G ratio of 2.91 and a beta of 0.76.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%. Danaher’s quarterly revenue was up 5.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.77 earnings per share. Sell-side analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s dividend payout ratio is 28.42%.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on DHR shares. TD Cowen boosted their price objective on shares of Danaher from $236.00 to $255.00 and gave the stock a “buy” rating in a report on Tuesday. Weiss Ratings upgraded Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, September 16th. Barclays increased their price target on Danaher from $230.00 to $255.00 and gave the company an “overweight” rating in a report on Wednesday, October 7th. Guggenheim raised their price objective on Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a research note on Thursday, October 1st. Finally, Morgan Stanley lifted their price objective on Danaher from $220.00 to $240.00 and gave the stock an “overweight” rating in a report on Monday. Two research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $235.41.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.